SAWAI GROUP HOLDINGS Co., Ltd. Logo

SAWAI GROUP HOLDINGS Co., Ltd.

A leading Japanese generic drug maker expanding into digital health and wellness solutions.

4887 | T

Overview

Corporate Details

ISIN(s):
JP3323040000
LEI:
Country:
Japan
Address:
大阪市淀川区宮原5丁目2−30
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Sawai Group Holdings Co., Ltd. is a holding company primarily engaged in the pharmaceutical business. Its core subsidiary, Sawai Pharmaceutical Co., Ltd., is a leading Japanese manufacturer of generic drugs, focusing on the research, development, production, and sale of high-quality, affordable medications across various therapeutic areas, including treatments for hypertension and dyslipidemia. The Group aims to contribute to reducing patient financial burdens and supporting sustainable healthcare systems. In addition to its core generics business, the company is expanding into the broader healthcare field, including digital health solutions and wellness services through subsidiaries such as FrontAct, which develops treatment support apps and provides health monitoring devices. The Group's mission is to support healthier lives for people worldwide.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-14 07:13
Interim Report
確認書
Japanese 9.1 KB
2025-11-14 07:12
Interim Report
半期報告書-第5期(2025/04/01-2026/03/31)
Japanese 335.3 KB
2025-10-31 03:04
Registration Form
訂正発行登録書
Japanese 24.2 KB
2025-06-27 02:47
Regulatory News Service
訂正発行登録書
Japanese 10.0 KB
2025-06-26 07:49
Post-Annual General Meeting Information
臨時報告書
Japanese 31.2 KB
2025-06-24 08:06
Governance Information
内部統制報告書-第4期(2024/04/01-2025/03/31)
Japanese 24.3 KB
2025-06-24 08:06
Registration Form
確認書
Japanese 9.0 KB
2025-06-24 08:05
Annual Report
有価証券報告書-第4期(2024/04/01-2025/03/31)
Japanese 2.0 MB
2025-05-27 05:40
Registration Form
訂正発行登録書
Japanese 9.6 KB
2025-05-27 02:50
Regulatory News Service
臨時報告書
Japanese 20.1 KB
2025-04-03 06:28
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 23.4 KB
2025-03-05 07:02
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 27.8 KB
2025-02-05 07:08
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 28.2 KB
2025-01-08 07:53
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 27.7 KB
2024-12-04 07:05
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 28.5 KB

Automate Your Workflow. Get a real-time feed of all SAWAI GROUP HOLDINGS Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SAWAI GROUP HOLDINGS Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SAWAI GROUP HOLDINGS Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

VivoSim Labs, INC. Logo
Offers 3D human tissue models for predictive toxicology testing to accelerate drug discovery.
United States of America
VIVS
Develops innovative, non-narcotic drugs for pain and central nervous system (CNS) diseases.
South Korea
082800
VOLITIONRX LTD Logo
Develops epigenetic blood tests for early cancer and sepsis detection in human/veterinary markets.
United States of America
VNRX
vTv Therapeutics Inc. Logo
Develops oral small molecule drugs for type 1 diabetes and other chronic conditions.
United States of America
VTVT
VYNE Therapeutics Inc. Logo
Clinical-stage biopharma developing novel therapies for immuno-inflammatory diseases.
United States of America
VYNE
WAKAMOTO PHARMACEUTICAL CO.,LTD. Logo
Develops gastrointestinal and ophthalmic drugs for the health challenges of an aging society.
Japan
4512
Wave Life Sciences Ltd. Logo
Developing RNA-based medicines for severe genetic diseases like DMD and Huntington's disease.
United States of America
WVE
WELLBIOTEC CO.,LTD Logo
Diversified in biopharma, EV chargers, and lithium supply for batteries.
South Korea
010600
Werewolf Therapeutics, Inc. Logo
Developing tumor-activated immunotherapies for a localized immune attack on cancer.
United States of America
HOWL
WHANIN PHARM CO.,LTD Logo
Develops and sells pharmaceuticals, specializing in CNS, cardiovascular, and GI drugs.
South Korea
016580

Talk to a Data Expert

Have a question? We'll get back to you promptly.